Ascendis Pharma
ASND
ASND
92 hedge funds and large institutions have $2.49B invested in Ascendis Pharma in 2018 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+27
Holders Change %
+41.54%
% of All Funds
2.11%
Holding in Top 10
14
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+16.67%
% of All Funds
0.32%
New
35
Increased
27
Reduced
25
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$87.6M |
2 |
VMI
VHCP Management II
New York
|
-$34.5M |
3 |
DM
Deerfield Management
New York
|
-$20M |
4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$18.6M |
5 |
GTC
Ghost Tree Capital
New York
|
-$7.19M |